Multistate medical cannabis operator Trulieve Cannabis Corp. announced last week that the company expects to begin trading on the New York Stock Exchange (NYSE) under the symbol “TRLV” beginning June 10, 2026.
The announcement follows the rescheduling of state legal medical cannabis from Schedule I to Schedule III under federal law, creating new legal avenues and opportunities for state-licensed medical cannabis companies.
“As the first U.S. cannabis company to list on a major U.S. stock exchange, we are excited about the opportunity to expand our shareholder base, increase liquidity and increase awareness of the benefits of medical marijuana. President Trump’s sensible action to reclassify medical marijuana to Schedule III paved the way for this milestone. The NYSE is a major breakthrough and great progress for the NYSE industry.” – Kim Rivers, Founder and CEO of Trulieve, in a statement
Trulieve operates state-licensed cannabis businesses in Florida, Georgia, Pennsylvania and West Virginia.
The multi-state operator is listing on the NYSE after previously listing on the Canadian Securities Exchange (CSE) under the symbol “TRUL” and the OTCQX under the symbol “TCNNF”.
Trulieve donated heavily to Florida’s failed 2024 cannabis legalization, bringing over $140 million to the effort. The company also contributed $19.6 million to the unsuccessful 2026 campaign bid.
